Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Abstract
Lazarus, Jeffrey V.; Newsome, Philip N.; Francque, Sven M.; Kanwal, Fasiha; Terrault, Norah A.; Rinella, Mary E. Author Information
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Once MASLD progresses beyond steatosis to steatohepatitis with fibrosis, there is substantial risk of cirrhosis, liver failure, and hepatocellular carcinoma.
“Once MASLD progresses beyond steatosis to steatohepatitis with fibrosis, there is substantial risk of cirrhosis, liver failure, and hepatocellular carcinoma.124,125”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [124]
Deposition of ectopic fat in the liver among susceptible individuals can lead to the development of MASLD.
“Deposition of ectopic fat in the liver among susceptible individuals can lead to the development of MASLD.124”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [124]
Cites
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000520 · Cited by 3,476 · see citing works
Self-citationCan we use old NAFLD data under the new MASLD definition?
Song, S. J., Lai, J. C.-T., Wong, G. L.-H., Wong, V. W.-S., & Yip, T. C.-F. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.021 · Cited by 374 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811 · see citing works
Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23052 · Cited by 776 · see citing works
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274 · see citing works
Cuthbertson, D. J., Keating, S. E., Pugh, C. J. A., Owen, P. J., Kemp, G. J., Umpleby, M., Geyer, N. G., Chinchilli, V. M., & Stine, J. G. (2024) · Liver International · doi:10.1111/liv.15947 · Cited by 38 · see citing works
Mortality outcomes in individuals with MASLD <i>versus</i> MASLD and increased alcohol intake
Aboona, M. B., Danpanichkul, P., Chen, V. L., Rangan, P., Kim, D., Alkhouri, N., Fallon, M. B., Noureddin, M., Arab, J. P., & Wijarnpreecha, K. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16726 · Cited by 29 · see citing works
Physiological and pathophysiological actions of insulin in the liver
Kubota, N., Kubota, T., & Kadowaki, T. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0192 · Cited by 19 · see citing works
Huang, Y., Wang, Y., Xiao, Z., Yao, S., Tang, Y., Zhou, L., Wang, Q., Xie, Y., Zhang, L., Zhou, Y., et al. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03580-6 · Cited by 16 · see citing works
- Authors
- Lazarus, J. V., Newsome, P. N., Francque, S. M., Kanwal, F., Terrault, N. A., & Rinella, M. E.
- Affiliations
- The Graduate Center, CUNY (US)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Antwerp (BE)
- Michael E. DeBakey VA Medical Center (US)
- University of Southern California (US)
- University of Chicago (US)
- Corresponding author
- Rinella, Mary E.
- ORCID
- Venue
- Hepatology
- Published
- 2023-11-20
- Volume
- 79
- Issue
- 3
- Pages
- E93-E94
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4388817250
- Cited by
- 438
- References
- 2
- Citations by year
- 2026: 66 · 2025: 103 · 2024: 168 · 2023: 101
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- hepatic steatosis, nomenclature, Delphi consensus, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, disease classification
- MeSH terms
- Consensus Statements as Topic, Consensus Development Conferences as Topic, Delphi Technique, Humans, Consensus, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
